Similar articles for PMID: 23395350

Year	Number of Results
1996	1
1997	1
1999	1
2000	3
2001	2
2002	4
2003	5
2004	7
2005	5
2006	5
2007	7
2008	9
2009	5
2010	7
2011	6
2012	7
2013	11
2014	8
2015	7
2016	16
2017	10
2018	8
2019	11
2020	4
2021	11
2022	3
2024	0

1

Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?

Hamid H, Kanner AM. Hamid H, et al. Epilepsy Behav. 2013 Mar;26(3):261-5. doi: 10.1016/j.yebeh.2012.10.009. Epub 2013 Feb 8. Epilepsy Behav. 2013. PMID: 23395350 Review.

2

Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence.

Kanner AM. Kanner AM. Epilepsy Behav. 2016 Aug;61:282-286. doi: 10.1016/j.yebeh.2016.03.022. Epub 2016 May 25. Epilepsy Behav. 2016. PMID: 27236241 Free article. Review.

3

Antidepressants for people with epilepsy and depression.

Maguire MJ, Weston J, Singh J, Marson AG. Maguire MJ, et al. Cochrane Database Syst Rev. 2014 Dec 3;2014(12):CD010682. doi: 10.1002/14651858.CD010682.pub2. Cochrane Database Syst Rev. 2014. PMID: 25464360 Free PMC article. Updated. Review.

4

The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?

Ribot R, Ouyang B, Kanner AM. Ribot R, et al. Epilepsy Behav. 2017 May;70(Pt A):5-9. doi: 10.1016/j.yebeh.2017.02.032. Epub 2017 Apr 10. Epilepsy Behav. 2017. PMID: 28407526

5

Preclinical antiepileptic actions of selective serotonin reuptake inhibitors--implications for clinical trial design.

Igelström KM. Igelström KM. Epilepsia. 2012 Apr;53(4):596-605. doi: 10.1111/j.1528-1167.2012.03427.x. Epub 2012 Mar 14. Epilepsia. 2012. PMID: 22416943 Free article. Review.

6

Antidepressants for people with epilepsy and depression.

Maguire MJ, Marson AG, Nevitt SJ. Maguire MJ, et al. Cochrane Database Syst Rev. 2021 Apr 16;4(4):CD010682. doi: 10.1002/14651858.CD010682.pub3. Cochrane Database Syst Rev. 2021. PMID: 33860531 Free PMC article.

7

Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.

Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC. Papakostas GI, et al. Biol Psychiatry. 2007 Dec 1;62(11):1217-27. doi: 10.1016/j.biopsych.2007.03.027. Epub 2007 Jun 22. Biol Psychiatry. 2007. PMID: 17588546 Review.

8

Vortioxetine: a New Treatment for Major Depressive Disorder.

Connolly KR, Thase ME. Connolly KR, et al. Expert Opin Pharmacother. 2016;17(3):421-31. doi: 10.1517/14656566.2016.1133588. Expert Opin Pharmacother. 2016. PMID: 26679430 Review.

9

Agomelatine versus other antidepressive agents for major depression.

Guaiana G, Gupta S, Chiodo D, Davies SJ, Haederle K, Koesters M. Guaiana G, et al. Cochrane Database Syst Rev. 2013 Dec 17;(12):CD008851. doi: 10.1002/14651858.CD008851.pub2. Cochrane Database Syst Rev. 2013. PMID: 24343836 Review.

10

Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.

Huang KL, Lu WC, Wang YY, Hu GC, Lu CH, Lee WY, Hsu CC. Huang KL, et al. Aust N Z J Psychiatry. 2014 Jul;48(7):663-71. doi: 10.1177/0004867414525837. Epub 2014 Mar 6. Aust N Z J Psychiatry. 2014. PMID: 24604920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

150 results

Results by year